ACE and early-onset autosomal dominant Alzheimer disease: Alzheimer disease (AD) is a leading cause of morbidity worldwide, and its prevalence is projected to increase in line with the aging global population.1 Several preclinical and observational studies have implicated the role of CNS angiotensin-converting enzyme (ACE) levels in the pathogenesis of AD.